Literature DB >> 4052931

Protective effect of liposomal-amphotericin B against C. albicans infection in mice.

G Lopez-Berestein, T McQueen, K Mehta.   

Abstract

The efficacy of free amphotericin B (AmpB) and liposomal-amphotericin B (L-AmpB) in the protection against C. albicans infection in mice was studied. Mice injected with a single dose of L-AmpB (1-4 mg/kg) two days prior to the yeast inoculation had an increased survival time when compared to animals injected with lower doses (0.8 mg/kg) of free AmpB or L-AmpB. L-AmpB (4 mg/kg of body weight) conferred protection against the fungal infection even when administered as a single dose five days prior to the yeast inoculation. A single-dose regimen of free AmpB showed a protective effect only when administered two days prior to the inoculum. When mice were challenged with larger yeast inocula, protection was seen with L-AmpB (4 mg/kg) or with multiple doses of free AmpB (0.8 mg/kg daily x 5) and not with single doses of free AmpB. In this group of mice, only animals treated with L-AmpB were microbiologically free of infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4052931     DOI: 10.1089/cdd.1985.2.183

Source DB:  PubMed          Journal:  Cancer Drug Deliv        ISSN: 0732-9482


  3 in total

Review 1.  Liposomes as drug delivery system in the treatment of infectious diseases. Potential applications and clinical experience.

Authors:  A Coune
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

Review 2.  Liposomes as carriers of antimicrobial agents.

Authors:  G Lopez-Berestein
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

3.  Liposome-encapsulated ampicillin against Listeria monocytogenes in vivo and in vitro.

Authors:  I A Bakker-Woudenberg; A F Lokerse; J C Vink-van den Berg; F H Roerdink
Journal:  Infection       Date:  1988       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.